Nutrien (NYSE:NTR) Price Target Cut to $52.00 by Analysts at UBS Group

Nutrien (NYSE:NTR) had its price objective lowered by investment analysts at UBS Group from $54.00 to $52.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. UBS Group’s target price would indicate a potential downside of 2.86% from the company’s previous close.

NTR has been the topic of several other reports. Piper Sandler boosted their target price on Nutrien from $58.00 to $63.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Royal Bank of Canada restated an “outperform” rating and issued a $60.00 price objective on shares of Nutrien in a research note on Monday, February 24th. Mizuho increased their target price on shares of Nutrien from $52.00 to $55.00 and gave the stock a “neutral” rating in a research report on Thursday, February 20th. Berenberg Bank boosted their price target on shares of Nutrien from $54.00 to $59.00 and gave the company a “buy” rating in a research report on Tuesday. Finally, BNP Paribas raised shares of Nutrien to a “strong-buy” rating in a report on Wednesday, April 9th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Nutrien has a consensus rating of “Moderate Buy” and an average price target of $59.40.

Nutrien Stock Performance

Shares of NYSE NTR traded up $1.31 during mid-day trading on Wednesday, reaching $53.53. 697,286 shares of the company’s stock were exchanged, compared to its average volume of 2,063,592. The firm has a 50-day moving average price of $50.78 and a two-hundred day moving average price of $49.18. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The firm has a market capitalization of $26.17 billion, a price-to-earnings ratio of 39.02, a price-to-earnings-growth ratio of 1.19 and a beta of 0.77. Nutrien has a 52 week low of $43.70 and a 52 week high of $60.87.

Nutrien (NYSE:NTR) last announced its quarterly earnings data on Wednesday, February 19th. The company reported $0.28 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.09). Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The company had revenue of $5.08 billion during the quarter, compared to the consensus estimate of $5.09 billion. Analysts predict that Nutrien will post 3.72 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of NTR. Fairway Wealth LLC purchased a new stake in Nutrien during the fourth quarter valued at approximately $27,000. HHM Wealth Advisors LLC raised its holdings in Nutrien by 331.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 625 shares of the company’s stock worth $28,000 after purchasing an additional 480 shares during the period. Assetmark Inc. lifted its position in Nutrien by 1,437.5% during the fourth quarter. Assetmark Inc. now owns 738 shares of the company’s stock valued at $33,000 after purchasing an additional 690 shares in the last quarter. Asset Planning Inc bought a new stake in Nutrien during the fourth quarter valued at about $35,000. Finally, Exchange Traded Concepts LLC grew its holdings in Nutrien by 96.7% during the fourth quarter. Exchange Traded Concepts LLC now owns 846 shares of the company’s stock valued at $38,000 after purchasing an additional 416 shares during the period. Institutional investors own 63.10% of the company’s stock.

About Nutrien

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.